208 related articles for article (PubMed ID: 37946250)
1. p63 orchestrates serine and one carbon metabolism enzymes expression in head and neck cancer.
Cappello A; Tosetti G; Smirnov A; Ganini C; Yang X; Shi Y; Wang Y; Melino G; Bernassola F; Candi E
Biol Direct; 2023 Nov; 18(1):73. PubMed ID: 37946250
[TBL] [Abstract][Full Text] [Related]
2. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
4. Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck.
Thurfjell N; Coates PJ; Boldrup L; Lindgren B; Bäcklund B; Uusitalo T; Mahani D; Dabelsteen E; Dahlqvist A; Sjöström B; Roos G; Vojtesek B; Nenutil R; Nylander K
Adv Otorhinolaryngol; 2005; 62():49-57. PubMed ID: 15608417
[TBL] [Abstract][Full Text] [Related]
5. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
6. p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure.
Gwosdz C; Balz V; Scheckenbach K; Bier H
Adv Otorhinolaryngol; 2005; 62():58-71. PubMed ID: 15608418
[TBL] [Abstract][Full Text] [Related]
7. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.
Zhou H; Cao T; Li WP; Wu G
Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892
[TBL] [Abstract][Full Text] [Related]
8. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex.
Verduci L; Ferraiuolo M; Sacconi A; Ganci F; Vitale J; Colombo T; Paci P; Strano S; Macino G; Rajewsky N; Blandino G
Genome Biol; 2017 Dec; 18(1):237. PubMed ID: 29262850
[TBL] [Abstract][Full Text] [Related]
10. Gleevec suppresses p63 expression in head and neck squamous cell carcinoma despite p63 activation by DNA-damaging agents.
Ongkeko WM; An Y; Chu TS; Aguilera J; Dang CL; Wang-Rodriguez J
Laryngoscope; 2006 Aug; 116(8):1390-6. PubMed ID: 16885742
[TBL] [Abstract][Full Text] [Related]
11. Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.
Ge L; Smail M; Meng W; Shyr Y; Ye F; Fan KH; Li X; Zhou HM; Bhowmick NA
PLoS One; 2011; 6(11):e27529. PubMed ID: 22096589
[TBL] [Abstract][Full Text] [Related]
12. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
Starska-Kowarska K
Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
[TBL] [Abstract][Full Text] [Related]
13. Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck.
Li X; Ottosson S; Wang S; Jernberg E; Boldrup L; Gu X; Nylander K; Li A
BMC Cancer; 2015 May; 15():342. PubMed ID: 25929687
[TBL] [Abstract][Full Text] [Related]
14. NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner.
Cai BH; Bai ZY; Lien CF; Yu SJ; Lu RY; Wu MH; Wu WC; Chen CC; Hsu YC
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327630
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling analysis of head and neck squamous cell carcinoma.
Ohashi T; Terazawa K; Shibata H; Inoue N; Ogawa T
Oral Dis; 2024 Mar; 30(2):342-352. PubMed ID: 36349421
[TBL] [Abstract][Full Text] [Related]
16. KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.
Ingruber J; Savic D; Steinbichler TB; Sprung S; Fleischer F; Glueckert R; Schweigl G; Skvortsova II; Riechelmann H; Dudás J
Cells; 2021 Mar; 10(3):. PubMed ID: 33802627
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 in head and neck squamous cell carcinoma: Molecular mechanism of gain‑of‑function and targeting therapy (Review).
Li M; Sun D; Song N; Chen X; Zhang X; Zheng W; Yu Y; Han C
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37449494
[TBL] [Abstract][Full Text] [Related]
18. PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.
Ganci F; Pulito C; Valsoni S; Sacconi A; Turco C; Vahabi M; Manciocco V; Mazza EMC; Meens J; Karamboulas C; Nichols AC; Covello R; Pellini R; Spriano G; Sanguineti G; Muti P; Bicciato S; Ailles L; Strano S; Fontemaggi G; Blandino G
Clin Cancer Res; 2020 Jun; 26(12):2956-2971. PubMed ID: 31969334
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of splicing proteins in head and neck squamous cell carcinoma.
Radhakrishnan A; Nanjappa V; Raja R; Sathe G; Chavan S; Nirujogi RS; Patil AH; Solanki H; Renuse S; Sahasrabuddhe NA; Mathur PP; Prasad TS; Kumar P; Califano JA; Sidransky D; Pandey A; Gowda H; Chatterjee A
Cancer Biol Ther; 2016; 17(2):219-29. PubMed ID: 26853621
[TBL] [Abstract][Full Text] [Related]
20. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
